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Various gastrointestinal inﬁltrations have been described in patients with chronic lymphocytic leukaemia (CLL). Here, we report
a 69-year-old man with CLL and anaemia in whom the macroscopic ﬁnding of colonoscopy was normal, but the histological
specimens revealed lymphocytic leukemia in ileum and in colon. If a CLL patient has any symptoms suggesting a possible GI
manifestation of the haematologic disease or anaemia not explained by bone marrow inﬁltration or hemolysis, the diagnostic
evaluation should include endoscopies with adequate biopsies.
Copyright © 2008 P. E. T. Arkkila et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Gastrointestinal manifestations have only very rarely been
described in patients with chronic lymphocytic leukaemia
(CLL). The lymphocytic inﬁltration seems to depend on the
tumour burden and proliferation activity [1]. Conventional
staging according to Rai or Binet may not accurately reﬂect
the whole extent of the disease. It is not known if CLL
patients should possibly be candidates for an endoscopic
investigation and whether proof of gastrointestinal involve-
ment would inﬂuence the treatment decisions.
We present a CLL patient who underwent gastrointesti-
nal endoscopies because of anaemia and who was found
to have colonic histological CLL manifestations in spite of
normal macroscopic appearance of the mucosa.
2. CASE REPORT
The patient is a 69-year-old-man, an exsmoker with chronic
atrialﬁbrillationandchronicotitisandwarfarinanddigitalis
ashis only medications. Hispast medical history wasunrem-
arkable until the end of 2001, when he started to have pro-
ductive cough and was found to have mild leukocytosis. In
2002, the plain chest x-ray was ﬁrst considered to be sugges-
tive of sarcoidosis. The CT scan showed lymphadenopathy
(max. 2cm) in both pulmonary hilar areas, in the axillae,
and also below the diaphragm, the ultrasound examination
also in the jugular and supraclavicular areas. The patho-
logical examination of mediastinoscopic paratracheal and
subcarinal lymph node biopsies showed eﬀacement of the
normal lymph node architecture by inﬁltration of small,
CD5+, CD20+, and CD23+ lymphatic cells with vague
pseudofollicular organization consistent with the diagnosis
of small B-cell lymphocytic lymphoma/CLL. Neither CD38
nor overexpression of p53 was observed by immunohisto-
chemistry, but the lymphoma cells expressed ZAP-70 as an
adverse prognostic factor.
In 2002, the haemoglobin level was 133–139g/L, the
white cell count 11.0–12.9 × 10E9/L with 59% lymphocytes,
the platelet count 191–289 × 10E9/L, and the Coombs test
negative. Elevated levels of the plasma lactate dehydrogenase
activity, 967U/l (normal below 450U/l), and the serum
thymidine kinase activity, 34U/l (normal below 8U/l), were
found. The bone marrow aspirate showed a decreased
proportion of erythropoiesis as well as granulopoiesis and
an increased proportion of small mature lymphocytes, up to
80–90% of the cellularity.
The bone marrow biopsy showed 60% overall cellularity.
60% of cells were interstitially and diﬀusely between tra-
beculae, inﬁltrating small lymphocytes admixed with scarce2 Gastroenterology Research and Practice
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Figure 1: Biopsy specimens revealed multiple diﬀuse CD20
positive (a) B-cell inﬁltrates involving mucosa and submucosa of
colon without formation lymphoepithelial lesions. B-lymphocytes
expressed also CD5 with low intensity (b) and CD23 (c), character-
istic of small lymphocytic lymphoma (CLL).
prolymphocytes and paraimmunoblasts. The immunophe-
notype was identical to the lymph node inﬁltrate.
Notreatmentwasconsiderednecessary,andthepatientc ¸s
clinical condition remained stable during 2002-2003. In
the follow up CT’s the size of lymph nodules remained
similar. The cough had disappeared, and the patient did
not have any general symptoms such as fever, abnormal
sweating, or weight loss. A small two-component IgG kappa
serum paraprotein (2.6g/L + 1.0g/L) was detected. In 2004,
after a left-sided pneumonia, slight progression of the
lymphadenopathy in the left pulmonary hilus, para-aortal,
and mesenterial regions was found without splenomegaly.
In spite of that, as well as the appearance of mild night
sweats, treatment was not considered necessary, as the
leukocyte count was only 22.7 × 10E9/L, and no anaemia
or thrombocytopenia was found. In the bone marrow, a
65–70% lymphatic inﬁltrate with slight enhancement in the
proportion of prominent, paraimmunoblast-type cells was
seen, the overall cellularity being 45%. The peripheral blood
cytogenetic analysis revealed 12-trisomy and translocation
t(4;12), whereas no signs of p53 deletion in chromosome 17,
the ATM gene deletion in 11q, or deletion 13q were found by
FISH-analysis.
In 2004, the haemoglobin gradually decreased from
a level of above 130g/L to 110g/L without increase in
lymphocytosis or signs of hemolysis but with mild throm-
bocytosis. The serum iron content and the transferrin
saturation were low (6.5umol/L and 9%, resp.), and when
checked in August, one out of three fecal tests positive
for occult blood. Folic acid (214nmol/L) and B12-vitamin
(380pmol/l) were within normal range. Serum albumin
(40.0g/L) and ionized calcium (1.18mmol/L/pH7.4) did not
suggest that the patient would have had malabsorption.
Some ﬂuctuation in INR value was found in 2004, but the
value was most of the time within the therapeutic range. The
transaminases and plasma creatinine were normal. Because
thehaemoglobin remainedabnormal(114–117g/L)andalso
microcytosis developed, endoscopies were arranged to assess
the possibility of gastrointestinal bleeding. No symptoms
suggesting a gastrointestinal cause for the anaemia existed.
In the gastroscopy, a sliding hernia but no signs of any
sources for upper gastrointestinal bleeding were found. The
gastroscopy biopsies showed chronic gastritis in the antrum
and in the corpus. No active gastritis, atrophic gastritis,
H. pylori, or duodenal villous atrofy were found. Also,
ileocolonoscopy was performed with colonic diverticulosis
as the diagnosis. Otherwise, the macroscopic view appeared
normal both in the colon and in the ileum.
Microscopicallydense mucosaland submucosallympho-
cytic inﬁltrates were detected in ileum as well as 4/7 biopsies
of colon (Figures 1(a), 1(b),a n d1(c)), with predominance
of small CD20 positive lymphocytes. No lymphoepithelial
lesions were observed. The cells stained positively also
for CLL-associated antigens CD5 (low intensity), CD23,
and CD43, but were negative for mantle cell-associated
antigen cyclin D1. Consecutively, ZAP-70 was positive, and
no immunohistochemical staining for CD38 or p53 was
detected.
3. PATIENT’S OUTCOME, CURRENT TREATMENT
After the endoscopies, the patient was put on peroral iron
substitution. After four months, the haemoglobin level
had increased to 137g/L, and the patient experienced an
improvement in his general condition. Haemoglobin has
thereafterremainedwithinnormalrangeuntilsummer2006.
The most likely reason for the anaemia in 2004 was the
bloodlossfromtheGItrackandthehistologicallyconﬁrmed
CLL GI-manifestation was the underlying reason.Patient
has had no GI symptoms like melena, bloody stools, orP. E. T. Arkkila et al. 3
stomach pain and because the anaemia disappeared with
the iron substitution, no other endoscopic procedures like
capsuleendoscopyorradiologicalimagingofthesmallbowel
have been assessed. During last two years, haemoglobin
has slowly decreased (144–127) and leukocyte level has
increasedduetotheadvanceofCLL.Despiteadversetrisomy
12 karyotypic and ZAP-70+ immunophenotypic ﬁndings,
the clinical condition and the blood lymphocytosis have
continuously remained quite stable, and no active treatment
for CLL has been initiated.
4. DISCUSSION
Gastrointestinal (GI) CLL involvement is uncommon, and
the rare GI complications generally occur only after trans-
formation of CLL to diﬀuse large B-cell lymphoma (Richter
syndrome). Our patient case shows that intestinal manifesta-
tions can appear even without any symptoms and without
macroscopic signs of CLL in the GI tract. Endoscopies
including biopsies are necessary in excluding possible gas-
trointestinal CLL manifestations. They should be performed
especially for patients having GI symptoms or anaemia.
Recent ﬁndings suggest that mantle cell lymphoma has
a much higher incidence of colonic presentation than prev-
iously reported [2]. It seems to appear mostly in asymp-
tomatic patients and is detected microscopically in 50%
of patients in a biopsy of a visually benign mucosa. Also,
patients with marginal zone B-cell lymphomas have a higher
incidence of colonic involvement than previously described.
Both of these lymphomas express the mucosal homing
receptor α4β7 especially when situated in the intestine [2–
5]. Also, primary follicular lymphoma of intestine is positive
for α4β7 in contrast to nodal follicular lymphoma [6]. Much
less is known about the incidence of colonic manifestations
of CLL/small lymphocytic lymphoma.
CLL may cause upper GI haemorrhage by directly inﬁl-
trating the gastroesophageal junction or through bleed-
ing from oesophageal varices caused by CLL-associated
splenomegaly and portal hypertension [7, 8]. According to
one case report, protein-losing enteropathy may be found in
CLL patients [9]. Reports also mention gastrointestinal CLL
manifestationssuchasinﬁltrationoftheintestinalmucosain
the small bowel as well as CLL presenting as colitis [10–12].
CLL, especially after Richter transformation, can cause signs
and symptoms suggestive of chronic inﬂammatory bowel
disease [12].
It has been reported that CLL sometimes occurs conco-
mitantly with other malignant neoplasms including mela-
noma, basal cell carcinoma, laryngeal carcinoma, and colon
carcinoma [13–15]. Both cellular and humoral immune
responses are often impaired in CLL patients, and the defec-
tive immunity in these patients may have had an etiological
role in the reported development and rapid progression of
their cancers. In the follow-up of CLL patients, we must,
therefore, be aware of the possible existence of a second
malignant disease [15, 16].
Gastrointestinal CLL manifestations can also form a
route for infectious complications. Sadullah et al. have repo-
rtedacase,wherelife-threateninggram-negativesepsisdeve-
loped in a patient with CLL in association with post-
chemotherapy neutropenia [17]. In colonoscopy, they found
a bacterial typhilitis or neutropenic enterocolitis, which is a
well described entity of bowel necrosis seen in immunosup-
pressed or neutropenic patients. It has also been suggested
that the small intestinal bacterial overgrowth can possibly
contributetothelymphoidinﬁltrationofthegastrointestinal
mucosa in CLL patients [18]. Other rare described CLL
manifestations include intussusception and even perforation
of the colon [19, 20].
The histopathologic diﬀerential diagnosis of common
benign lymphatic hyperplasias and various malignant lym-
phoid disorders of intestine may be challenging, and
biopsy specimens should be subjected to rigorous analy-
sis including immunophenotypic and possibly genotypic
studies. Abundant biopsy specimens are required to avoid
sampling error and to provide for adequate diagnostic
tissue material, which should be sent fresh without ﬁxative
to haematopathology laboratory. Fresh biopsy specimens
can usually be successfully subjected to ﬂowcytometric
analysisofimmunophenotypeandspeciﬁcallyimmunoglob-
ulin light chain restriction. Additionally, B-cell and T-
cell receptor gene rearrangement studies may be helpful
in detecting clonal lymphocyte populations. Immunohisto-
chemical staining of tissue sections enable correlation of the
immunophenotype to morphologic features. The diagnostic
range for CLL should include CD20+/CD5+ coexpression
with CD23+ phenotype, and negative staining pattern for
Cyclin D1 to exclude mantle cell lymphoma (lymphomatous
polyposis). Diﬀerential diagnosis of indolent CD5 nega-
tive B-cell lymphomas include follicular lymphoma, which
usually has CD10+ phenotype, whereas mucosa-associated
marginal zone-lymphoma (MALT-lymphoma) lacks speciﬁc
phenotypic markers and its immunophenotypic diagnosis
is mainly based on exclusion. Lymphoepithelial lesions
and plasmacytic diﬀerentiation are suggestive of MALT-
lymphoma.
In conclusion, also gastrointestinal evaluation should
perhaps be part of a complete assessment of the treatment
response and remission status in CLL patients in whom
the colon was originally involved. If a CLL patient has any
symptoms suggesting a possible GI manifestation of the
haematologic disease or anaemia not explained by bone
marrow inﬁltration, or hemolysis, the diagnostic evaluation
should include endoscopies with adequate biopsies.
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